The video demonstrates an assay using human induced pluripotent stem cell (iPSC)-derived CD8+ T cells to inhibit hepatitis B virus (HBV) replication in mice. These T cells, engineered with HBV-specific receptors, are transferred into transgenic mice. Replication-competent HBV genome plasmids are then injected directly into the liver, enabling viral DNA uptake. Once viral antigens are expressed and presented by hybrid MHC-I molecules, the engineered T cells recognize and bind to these complexes. This triggers the release of cytotoxic molecules, resulting in the destruction of HBV-infected liver cells and suppression of viral replication.
Protocol
All procedures involving animal models have been reviewed by the local institutional animal care committee and the JoVE veterinary review board. All procedures involving sample collection have been performed in accordance with the institute's IRB guidelines. 1. Generation of viral Ag-specific CD8+ T cells from iPSCs (iPSC-CD8+ T cells) Creation of the retroviral constructs NOTE: T-cell receptor (TCR) α an…
Representative Results
Figure 1: Generation of HBV viral Ag-specific iPSC-CD8+ T cells. Mouse iPSCs are transduced with the following retroviral constructs: HBs183-91 TCR (MiDR-s183 TCR) or OVA257–264 TCR (MiDR-OVA TCR), and the transduced iPSCs are co-cultured with OP9-DL1/DL4 stromal cells for T lineage differentiation. (A) Schematic representation of the retroviral constr…
Declarações
The authors have nothing to disclose.
Materials
HHD mice
Institut Pasteur, Paris, France
H-2 class I knockout, HLA-A2.1-transgenic (HHD) mice
iPS-MEF-Ng-20D-17
RIKEN Cell Bank
APS0001
SNL76/7
ATCC
SCRC-1049
OP9
ATCC
CRL-2749
pAAV/HBV1.2 plasmid
Dr. Dr. Pei-Jer Chen (National Taiwan University Hospital, Taiwan)
HBV DNA construct
HBs183-91(s183) (FLLTRILTI)-specific TCR genes
Dr. Adam J Gehring (Toronto General Hospital Research Institute, Toronto, Canada)
FLLTRILTI-specific A2-restricted human-murine hybrid TCR genes (Vα34 and Vβ28)
OVA257–264-specific TCR genes
Dr. Dario A. Vignali (University of Pittsburgh, PA)